<?xml version="1.0" encoding="UTF-8"?>
<ref id="R34">
 <label>34</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Tapia Rico</surname>
    <given-names>G</given-names>
   </name>, 
   <name name-style="western">
    <surname>Chan</surname>
    <given-names>MM</given-names>
   </name>, 
   <name name-style="western">
    <surname>Loo</surname>
    <given-names>KF</given-names>
   </name>
  </person-group>
  <article-title>The safety and efficacy of immune checkpoint inhibitors in patients with advanced cancers and pre-existing chronic viral infections (hepatitis B/C, HIV): a review of the available evidence</article-title>. 
  <source>Cancer Treat Rev</source>
  <year>2020</year>;
  <volume>86</volume>:
  <elocation-id>102011</elocation-id>. 
  <pub-id pub-id-type="doi">10.1016/j.ctrv.2020.102011</pub-id>
  <?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/32213376?>
  <pub-id pub-id-type="pmid">32213376</pub-id>
 </mixed-citation>
</ref>
